Research and Markets: Roche’s Quilizumab (Asthma) – Forecast and Market … – Business Wire (press release)

Research and Markets: Roche's Quilizumab (Asthma) – Forecast and Market
Business Wire (press release)
IgE is important in the development of allergic asthma, as it binds to mast cells and basophils, which play a significant role in the pathogenesis of asthma. IgE ultimately triggers the release of histamines, prostaglandins, and leukotrienes, which
Research and Markets: Cinquil (Reslizumab) Asthma Treatment – Forecast and Rock Hill Herald (press release)
Research and Markets: Roche's Lebrikizumab (Asthma) Treatment – Forecast DigitalJournal.com

all 3 news articles »

View full post on asthma – Google News

Novartis, Roche’s Xolair Help Blunt Severe Milk Allergies in Children – Bloomberg


MedIndia

Novartis, Roche's Xolair Help Blunt Severe Milk Allergies in Children
Bloomberg
Novartis AG (NOVN) and Roche Holding AG (ROG)'s Xolair, a medication used to treat asthma attacks caused by allergens such as pollen and dust mites, helped children overcome milk allergies, a small study
Xolair May Treat Milk Allergy in KidsWebMD
New treatment may desensitize kids with milk allergies, say researchers at Scope (blog)
Milk allergy treated with a new desensitization strategyChicago Tribune
U.S. News & World Report
all 44 news articles »

View full post on asthma – Google News